Selina R. McGee, OD, FAAO

Founder
BeSpoke Vision
Edmond, OK

Justin Schweitzer, OD, FAAO

Vance Thompson Vision
Sioux Falls, SD

William Trattler, MD

Cornea, Cataract and Refractive Surgeon
Center for Excellence in Eye Care
Clinical Associate Professor
Herbert Wertheim College of Medicine at Florida International University
Miami, Florida

Walter O. Whitley, OD, MBA, FAAO

Virginia Eye Consultants
EyeCare Partners, LLC
Norfolk, VA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

The following faculty/staff members have the following financial relationships with ineligible companies.

Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aldeyra, Allergan, Avellino, Bruder, Cynosure, Dompé, Eyevance, Horizon, Kala Pharmaceuticals, Lumenis, Novartis, Optovue, Oyster Point, RVL, Science Based Health, Sun Pharmaceuticals, Tarsus, Thea, Versant, and Vertical. Speaker’s Bureau: Allergan, Cynosure, Dompé, Horizon, Kala Pharmaceuticals, Lumenis, Oyster Point, RVL, and Optovue.

Justin Schweitzer, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie, Alcon, Allergan, Bausch + Lomb, Ocular Therapeutix, EyePoint, Sight Sciences, Dompe, Zeiss, Visus, Science Based Health, Kala, RVL, Sun, Reichert, J&J, Glaukos, Horizon, Quidel, MediPrint, LKC, Avellino, Novartis, Iveric bio, and Occuphire. Speaker’s Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Sight Sciences, Zeiss, Glaukos, and LKC.

William Trattler, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Avellino Labs, Avedro/Glaukos, Azura Ophthalmics, Bausch and Lomb, BVI, Centricity Vision, Dompe, Horizon, Johnson & Johnson, LENSAR, Ocular Science, Sight Sciences, Sun Pharma, Tarsus, TissueTech/BioTissue, Thea, Trefoil, Verséa Biologics, Visiox, Visus, and Zeiss. Speaker’s Bureau: Alcon, Allergan, Avedro/Glaukos, Bausch and Lomb, BVI, Oculus, Sun Pharma, and TissueTech/BioTissue. Grant/Research Support: Allergan, Bausch and Lomb, and CXLO. Shareholder: ArcScan, Aperta Bio, Blink Energy, CSI Dry Eye, CXLO, Guardian Health, Layerbio, Omega Ophthalmics, Orasis, RxSight, Tarsus, and Trefoil.

Walter O. Whitley, OD, MBA, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Eyenovia, Heru, Iveric Bio, MediPrint Ophthalmics, Regener-Eyes, RVL Pharmaceuticals, Santen, and Thea Pharma. Advisory Board: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Bruder, I-MED Pharma, Kala Pharmaceuticals, Oyster Point Pharma, RVL Pharmaceuticals, Santen, Science Based Health, Sun Pharmaceutical Industries, Tarsus, and Visus. Grant/Research Support: Heru. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Kala Pharmaceuticals, and Oyster Point Pharma. Editor: CollaborativeEye, Dry Eye Coach, and Review of Optometry. Co-Founder: New Sight Capital.

Diana Chu, OD has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant, Advisory Board, and Speaker’s Bureau: Bausch & Lomb, Alcon, Tarsus Pharmaceuticals, Orasis, Kala Pharmaceuticals, and Dompe.

Joshua Davidson, OD, FAAO, FSLS has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bruder Healthcare. Shareholder: Bausch Healthcare and Abbvie. Speaker’s Bureau: Allergan/Abbvie and Santen

Jason Ellen, OD has had no financial relationships or affiliations with an ineligible company.

Ahmad Fahmy, OD, FAAO has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Sight Sciences, Dompe, and NuSight Medical. Speaker's Bureau: Allergan, Oyster Point, Dompe, and BioTissue. Advisor: NovaBay.

Steven Ferrucci, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Icare. Speaker’s Bureau: Visionix, Regeneron, and LKC Technologies. Advisory Board: Science Based Health, Visible Genomics , Apellis Pharmaceuticals, Iveric Bio, Novartis, and Ocuterra.

Hardeep Kataria, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Sight Sciences. Speaker’s Bureau: Dompe and BioTissue.

John Kitchens, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Alimera, Apellis, Bayer, Biogen, B&L, Genentech, Kodiak, Outlook, and Regeneron. Speaker’s Bureau: Alcon, Allergan, Alimera, Apellis, Bayer, Biogen, B&L, Genentech, Kodiak, Outlook, and Regeneron. Grant/Research Support: Kodiak, Genentech, and Regeneron. Shareholder: Kodiak, Outlook, and Vortex.

Cecelia Koetting, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Aldyera, Allergan, Avallino, Bausch + Lomb, Bruder, Claris Bio, Dompé, Eyevance/Santen, Glaukos, Kala Pharmaceuticals, Myze, Orasis Pharmaceuticals, Oyster Point Pharma, RVL, Sight Sciences, Tarsus Pharmaceuticals, Théa Pharma, Twenty/Twenty, and Visus. Speaker’s Bureau: Alcon, Avallino, Bausch + Lomb, Dompé, Eyevance/Santen, Glaukos, Ivantis, Oyster Point Pharma, Sight Sciences, RVL. Grant/Research Support: Johnson & Johnson Vision, Tarsus, Ocular Therapeutics.

Jacob Lang, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aescuela Tech, Aldeyra, Alcon, Allergan, AOS, Avellino, Carl Zeiss Meditec, Dompé, Envision Biomedical, Horizon, Kala Pharmaceuticals, Novartis, Orasis Pharmaceuticals, Oyster Point Pharma, Sun Pharmaceutical Industries, Scope, Science Based Health, Sight Sciences, Tarsus Pharmaceuticals, and Théa Pharma. Speaker’s Bureau: Dompé, Oyster Point Pharma, and Sun Pharmaceutical Industries.

Carolyn Majcher, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Carl Zeiss Meditec, Regeneron Pharmaceuticals, Iveric Bio, Optomed, Apellis Pharmaceuticals, LENZ Therapeutics, Notal Vision, and Ocuterra. Speaker’s Bureau: Carl Zeiss Meditec, Regeneron Pharmaceuticals, Iveric Bio, and Optomed.

Rebecca Miller, OD has had no financial relationships or affiliations with an ineligible company.

Sherrol Reynolds, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s Bureau: American Diabetes Association (ADA), VSP, and Allergan.

Brian Shafer, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Alcon, Visus, Glaukos, and CorneaGen. Speaker’s Bureau: Alcon and AbbVie.

Jessica Steen OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Speakers Bureau: Carl Zeiss Meditec, Bausch and Lomb, Oyster Point. Advisory Board: Bausch and Lomb, Santen, Peripherex, Ocuphire, Ocuterra

Will To, OD ABO has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s Bureau: Bausch + Lomb, Sight Sciences, Optos, Scope Eyecare, and marketing4ECPs. Shareholder: Young ODs of America.

Gary Wörtz, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Johnson & Johnson Vision, Lensar, Ocular Science & Ocuphire, Tarsus, and TearClear. Shareholder: Arcuate Innovations, Johnson & Johnson, Ocular Science and Omega Ophthalmics. Speaker’s Bureau: AvaGen. Other: Advertising revenue from BioTissue, Dompé, Lensar, Ocular Science, Alcon and Carl Zeiss Meditec.

Rachael Wruble, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s Bureau: Allergan and Bausch & Lomb.

The Evolve and the Avenue Live staff and planners have no financial relationships with ineligible companies.